What Do We Know About the New SARS-CoV-2 Variant?
A new SARS-CoV-2 variant – currently referred to as B.1.1.529 – has been detected in South Africa after a rapid increase in cases over the last seven days. Here's what we know so far.
Genetic Analysis of Glioblastoma Brain Tumors Can Aid in Treatment Decisions
The study shows that genetic analysis of glioblastomas can predict the tumors' sensitivity to specific drugs.
PolyMedix Appoints Vice President of Drug Development
Timothy Henkel, Appointed Vice President of Drug Development and Chief Medical Officer.
Mobious Genomics Receives US Sequencing Patents
The patent has been subsequently re-examined and re-allowed and has now proceeded to grant.
Genesis Bioventures Announces Restructuring Management Agreement
Genesis Bioventures has retained Experigen Management Company to lead its reorganization and restructuring.
Identifying Changes in Regulation of Disease-Related Genes
GECM is using Applied Biosystems’ products to analyse disease-related genes.
deCODE Describes Genetic Risk Factor for Heart Attack
The study builds upon deCODE's previously published work linking variants of the gene.
Applied Biosystems to Webcast Presentation at First Analysis Investment Conference
Peter Dworkin, Vice President of Investor Relations and Corporate Communications will provide an overview of the business.
Publication Shows Cancer Biomarker Identification in Formalin-Fixed Tissue
The article describes LC MS/MS mass spectrometry analysis of FFPE prostate cancer tissue.
Galapagos Appoints Chief Financial Officer
David R. Smith has been appointed as Chief Financial Officer.
Acrongenomics Retains KGMC Group
KGMC Group will work with Acrongenomics to complete formal validations of the advanced Nano-JETA™ platform.